LEADER 01509nas  2200493 a 450 
001 9910144569503321
005 20240413020422.0
011   $a1557-8852
035   $a(OCoLC)45694108
035   $a(CKB)954925607868
035   $a(CONSER)  2005212454
035   $a(MiFhGG)2EOU
035   $a(MiAaPQ)33066
035   $a(DE-599)ZDB2520571-7
035   $a(EXLCZ)99954925607868
100   $a20010110a19969999  sy         a
101 0 $aeng
135   $aurcnu---|||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aCancer biotherapy & radiopharmaceuticals
210  1$aNew Rochelle, N.Y. :$cMary Ann Liebert, Inc.,$d1996-
215   $a1 online resource
300   $aRefereed/Peer-reviewed
311   $a1084-9785 
606   $aCancer$xTreatment$vPeriodicals
606   $aRadiopharmaceuticals$vPeriodicals
606   $aBiological products$xTherapeutics$vPeriodicals
606   $aBiological Products$xtherapeutic use
606   $aNeoplasms$xtherapy
606   $aRadioisotopes$xtherapeutic use
608   $aPeriodical.
615  0$aCancer$xTreatment
615  0$aRadiopharmaceuticals
615  0$aBiological products$xTherapeutics
615  2$aBiological Products$xtherapeutic use.
615  2$aNeoplasms$xtherapy.
615  2$aRadioisotopes$xtherapeutic use.
676   $a616
906   $aJOURNAL
912   $a9910144569503321
996   $aCancer biotherapy & radiopharmaceuticals$92088307
997   $aUNINA